![inPROBE is a device designed to speed up cancer diagnostic time](/sites/default/files/styles/oe_theme_medium_no_crop/public/2023-10/Optics.jpg?itok=I_iCyf8C)
SDS Optic
The European Investment Bank (EIB) has signed up to a €10 million loan agreement with EIC-funded Lublin-based Polish company SDS Optic Inc., publicly listed at Warsaw Stock Exchange (NC:SDS), to support the development and commercialisation of the diagnostic and monitoring photonic biosensing inPROBE® platform. The research and development activities backed will help advance a cutting-edge cancer detection technology. This agreement was made possible with the support of the InvestEU programme, which aims to trigger more than €372 billion in additional investment over the period 2021-27.
Beforehand, SDS Optic Inc. was backed up by the EIC Accelerator with nearly €4 million within the project SDS OmiProbe.
Details
- Publication date
- 2 October 2023